A Manhattan federal judge has ruled that an activist investor can be sued for allegedly making false statements in a heated proxy fight that got two of its nominees elected to a firm’s board of directors.

The decision, attorneys for plaintiff Enzo Biochem Inc. said, would give public companies a path to sue investors who make material misrepresentations in proxy statements while aggressively seeking to bring about corporate governance changes.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]